SCHEMBL25831698

SCHEMBL25831698

CC(C)(C)OC(=O)N1CCC(c2cnc3c(c2)[nH]c2ncnc(Cl)c23)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 1/20 0.47
▸ CRBN Q96SW2 1/20 0.47
▸ HPGDS O60760 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ WNT3A P56704 1/20 0.41
▸ JAK2 O60674 1/20 0.41
▸ JAK1 P23458 1/20 0.41
▸ TYK2 P29597 1/20 0.41
▸ JAK3 P52333 1/20 0.41
▸ BTK Q06187 1/20 0.41
▸ GPR119 Q8TDV5 3/20 0.40
▸ NAMPT P43490 1/20 0.40
▸ KIT P10721 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31188115 1.00 DDB1 (0.47) DDB1CRBNHPGDSKDM4EMAPT
SCHEMBL25263858 0.85 EGLN1 (0.38) —
SCHEMBL25831682 0.83 DDB1 (0.49) DDB1CRBNHPGDSKDM4EMAPT
SCHEMBL25831704 0.80 DDB1 (0.42) DDB1CRBNHPGDSKDM4EMAPT
SCHEMBL25831131 0.80 PDE4B (0.50) DDB1CRBNHPGDSMAPTJAK2
SCHEMBL31017634 0.80 PDE4B (0.50) DDB1CRBNHPGDSMAPTJAK2
SCHEMBL25427387 0.79 DDB1 (0.41) DDB1CRBNHPGDSKDM4EMAPT
SCHEMBL16048398 0.76 KDM4E (0.53) DDB1CRBNHPGDSKDM4EMAPT
SCHEMBL30729914 0.76 CNR1 (0.46) DDB1CRBNHPGDSKDM4EMAPT
SCHEMBL27309056 0.76 CNR1 (0.46) DDB1CRBNHPGDSKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118414336-A Degradation of Bruton Tyrosine Kinase (BTK) by conjugation of BTK inhibitors to E3 ligase ligands and methods of use 百济神州有限公司 2024-07-30 — — CN disclosed
WO-2023125907-A1 DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE BEIGENE, LTD. (KY) 2023-07-06 — — WO disclosed
Send feedback